Gyno-Pevaryl

Gyno-Pevaryl is a prescription vaginal product that contains the antifungal agent econazole nitrate. It is formulated for local application in the vagina and is marketed in the European Union for the treatment of fungal infections of the female genital tract.

Gyno-Pevaryl is indicated for the management of fungal infections affecting the vulva and vagina. It is commonly prescribed when a patient presents with symptoms of candidal overgrowth.

- Treatment of vulvovaginal candidiasis confirmed by clinical assessment - Use in recurrent yeast infections when other therapies have failed - Adjunct therapy for mixed infections involving Candida species - Prevention of recurrence after successful eradication of infection

Side effects of Gyno-Pevaryl are generally mild but can vary in frequency and severity.

Common: - Local irritation or burning sensation at the application site - Vaginal itching or discomfort - Mild discharge or spotting - Headache - Nausea - Abdominal cramps

Serious: - Severe allergic reaction (rash, swelling, difficulty breathing) - Persistent or worsening vaginal symptoms - Signs of secondary infection (fever, chills) - Unusual vaginal bleeding

Before using Gyno-Pevaryl, certain precautions should be considered to ensure safe and effective treatment.

- Confirm diagnosis of candidiasis before initiating therapy - Avoid use if known hypersensitivity to econazole or other imidazoles - Discuss pregnancy or breastfeeding status with a healthcare professional - Use only as directed; do not exceed recommended duration - Report any signs of an allergic reaction promptly - Keep the product out of reach of children and store according to label instructions

Gyno-Pevaryl may interact with other medications or substances when used concurrently.

Avoid: - Concurrent use of other vaginal antifungal agents without medical advice - Use with intravaginal products that may alter pH or barrier function (e.g., douches, spermicides)

Use with caution: - Systemic azole antifungals (may increase systemic exposure) - Hormonal contraceptives (potential alteration of efficacy) - Topical corticosteroids applied to the same area - Any medication that may cause liver enzyme changes (monitor if systemic absorption is suspected)